How do some people escape cancer despite high risk factors? This is the mystery that the French team ATLAS wants to discover, which has just secured large-scale international funding. Its track: auto-antibodies and their role in our natural defenses against the disease.
How do some people escape cancer despite high risk factors? This is the mystery that the French team ATLAS wants to discover, which has just secured large-scale international funding. Its track: auto-antibodies and their role in our natural defenses against the disease.
Why do some people never develop cancer, even when they are highly exposed to risk factors? It is the riddle that a team of French researchers wants to solve.